Fish oil infusion offers hope for babies with liver damage from IV feeding
NCT ID NCT02929303
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study provides expanded access to Omegaven, a fish oil infusion, for infants and children who developed liver disease from long-term IV nutrition. The goal is to lower high liver enzymes and bilirubin levels. Participants are children aged 0-18 who need IV nutrition for at least 30 days and have a direct bilirubin of 2 mg/dL or more.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL PARENTERAL NUTRITION-INDUCED CHOLESTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advocate Children's Hospital
Park Ridge, Illinois, 60068, United States
Conditions
Explore the condition pages connected to this study.